Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Goldman Sachs CFO Schwartz Granted 171,419 Restricted Shares Over 3-Yr Period

RELATED NEWS
Trade GS now with 

Goldman Sachs Group Inc. (GS: Quote) newly appointed chief financial officer or CFO Harvey Schwartz, owns 175,493 shares of the company and 171,419 restricted shares over a three-year period starting in 2011, according to a securities filing.

According to Securities and Exchange Commission filing, the restricted stock units can't be sold or transferred before dates ranging from January 2016 to January 2018.

The newly appointed CFO also has options to buy 302,888 shares at $78.78 that will expire in December 31, 2018. All of these stock options are vested and exercisable. If the stock options are exercised, the underlying shares of common stock generally cannot be sold or transferred before January 2014, the filing said.

Harvey Schwartz was one of three global co-heads of the sales and trading division before the New York-based firm announced in September that he would succeed David Viniar as CFO at the end of January.

Click here to receive FREE breaking news email alerts for Goldman Sachs Group Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks came under pressure in early trading on Friday and remained firmly in the red throughout the remainder of the trading session. With the losses on the day, the S&P 500 pulled back well off yesterday's record closing high. President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border. Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.